An open-label pilot study suggests that intravenous brexanolone may rapidly reduce psychotic, manic, and depressive symptoms in patients with postpartum psychosis, highlighting a potential new treatment option.
Virtual group prenatal care was linked to reduced stress and higher perceived quality of care, offering a promising model to support maternal well-being and access to care.
Postpartum bipolar disorder appears to have a somewhat distinct clinical profile in terms of timing and symptom pattern, but current evidence suggests it is better conceptualized as a subtype of bipolar disorder rather than a fully separate diagnostic entity.
Perinatal depression and anxiety remain underdiagnosed and undertreated despite ACOG guidelines recommending universal, repeated screening across pregnancy and postpartum visits.
We are pleased to share that our More Than Blue documentary is now screening across the globe through our new partnership with ROCO films.
The bill would ensure mental health evaluations by reproductive psychiatry experts, ensure treatment when needed, and recognize postpartum psychosis as a mitigating factor in sentencing.
The relationship between breastfeeding and postpartum depression is complex and bidirectional, with each influencing the other through biological, psychological, and social factors.
New documentary illuminates the faces and voices of postpartum depression across America.
While zuranolone may show promise for the treatment of depressive episodes in patients with bipolar disorder, more research is needed.
While the 2025 report indicates that the United States has made progress in training and deploying more maternal mental health providers, the risk for maternal mental health disorders is actually rising.
